West Pharmaceutical Services is the winner of the Product Launches Award for Prefillable Syringe Systems in the 2025 ...

Lupin has FDA approval for Armlupeg 6mg/0.6ml injection in a single-dose prefilled syringe, for subcutaneous use, as a biosimilar to Neulasta.

In 2024, over half of patients found to have HIV in Europe received a late diagnosis, which is often associated with poor ...

The proportion of children receiving a second dose of the MMR vaccine is still below the threshold to stop viral transmission ...

Not long after cutting its sales forecast for 2025, Valneva has decided to decrease its operational footprint in France by ...

The UK MHRA has granted approval to Roche Products’ inavolisib to treat adults diagnosed with HR-positive, HER2-negative ...

Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease ...

With an eye on 2026, the healthcare editorial team reflects on key takeaways and trends from recent pharma conferences.

Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales. A UK-developed cell therapy ...

As the US Centers for Medicare and Medicaid Services (CMS) has released the new prices for 15 drugs that have been added to ...

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Gilead now own the rights to Sprint's preclinical oncology immunotherapy programme, which targets the novel cancer target, ...